Latest Insider Transactions at Bridge Bio Pharma, Inc. (BBIO)
This section provides a real-time view of insider transactions for Bridge Bio Pharma, Inc. (BBIO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of BridgeBio Pharma, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of BridgeBio Pharma, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 20
2025
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
26,156
-3.53%
|
$1,700,140
$65.86 P/Share
|
|
Nov 18
2025
|
Andrew Lo Director |
SELL
Open market or private sale
|
Indirect |
55,000
-30.37%
|
$3,575,000
$65.64 P/Share
|
|
Nov 17
2025
|
Randal W. Scott Director |
SELL
Open market or private sale
|
Direct |
10,000
-26.23%
|
$660,000
$66.57 P/Share
|
|
Nov 17
2025
|
Randal W. Scott Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+31.66%
|
$160,000
$16.75 P/Share
|
|
Nov 17
2025
|
Andrew Lo Director |
SELL
Open market or private sale
|
Direct |
40,599
-44.26%
|
$2,679,534
$66.84 P/Share
|
|
Nov 17
2025
|
Thomas Trimarchi President and CFO |
SELL
Open market or private sale
|
Direct |
16,934
-2.14%
|
$1,117,644
$66.51 P/Share
|
|
Nov 16
2025
|
Neil Kumar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
32,855
-11.42%
|
$2,168,430
$66.39 P/Share
|
|
Nov 16
2025
|
Neil Kumar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
64,697
+7.35%
|
-
|
|
Nov 16
2025
|
Thomas Trimarchi President and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,317
-5.06%
|
$1,406,922
$66.39 P/Share
|
|
Nov 16
2025
|
Maricel Apuli Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,781
-3.49%
|
$315,546
$66.39 P/Share
|
|
Nov 12
2025
|
Hannah Valantine Director |
SELL
Open market or private sale
|
Direct |
25,484
-77.34%
|
$1,681,944
$66.07 P/Share
|
|
Nov 12
2025
|
Hannah Valantine Director |
BUY
Exercise of conversion of derivative security
|
Direct |
25,484
+43.61%
|
$1,223,232
$48.45 P/Share
|
|
Nov 07
2025
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-0.48%
|
$2,440,000
$61.93 P/Share
|
|
Nov 06
2025
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-0.47%
|
$2,520,000
$63.62 P/Share
|
|
Nov 06
2025
|
Ronald J Daniels Director |
SELL
Open market or private sale
|
Direct |
61,031
-78.22%
|
$3,844,953
$63.72 P/Share
|
|
Nov 06
2025
|
Ronald J Daniels Director |
BUY
Exercise of conversion of derivative security
|
Direct |
61,031
+43.89%
|
$2,075,054
$34.65 P/Share
|
|
Oct 29
2025
|
Frank Mccormick Director |
SELL
Open market or private sale
|
Indirect |
198,359
-4.89%
|
$13,290,053
$67.39 P/Share
|
|
Oct 27
2025
|
Frank Mccormick Director |
SELL
Open market or private sale
|
Indirect |
1,641
-0.19%
|
$106,665
$65.0 P/Share
|
|
Oct 09
2025
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-1.38%
|
$2,160,000
$54.8 P/Share
|
|
Oct 08
2025
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-0.68%
|
$2,160,000
$54.74 P/Share
|
|
Sep 05
2025
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-0.44%
|
$2,080,000
$52.97 P/Share
|
|
Sep 05
2025
|
Frank Mccormick Director |
SELL
Open market or private sale
|
Direct |
74,000
-47.05%
|
$3,922,000
$53.16 P/Share
|
|
Sep 05
2025
|
Frank Mccormick Director |
BUY
Exercise of conversion of derivative security
|
Direct |
74,000
+32.0%
|
$814,000
$11.92 P/Share
|
|
Sep 04
2025
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-0.65%
|
$2,040,000
$51.5 P/Share
|
|
Aug 21
2025
|
Thomas Trimarchi President and CFO |
SELL
Open market or private sale
|
Direct |
42,237
-9.12%
|
$2,069,613
$49.48 P/Share
|
|
Aug 20
2025
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
26,156
-5.26%
|
$1,281,644
$49.03 P/Share
|
|
Aug 18
2025
|
Thomas Trimarchi President and CFO |
SELL
Open market or private sale
|
Direct |
17,353
-1.81%
|
$867,650
$50.54 P/Share
|
|
Aug 16
2025
|
Thomas Trimarchi President and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
21,317
-4.25%
|
$1,087,167
$51.32 P/Share
|
|
Aug 16
2025
|
Maricel Apuli Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,781
-3.37%
|
$243,831
$51.32 P/Share
|
|
Aug 16
2025
|
Neil Kumar Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
32,855
-11.65%
|
$1,675,605
$51.32 P/Share
|
|
Aug 16
2025
|
Neil Kumar Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
64,697
+18.66%
|
-
|
|
Aug 11
2025
|
Charles J Homcy |
SELL
Open market or private sale
|
Direct |
50,000
-5.17%
|
$2,400,000
$48.0 P/Share
|
|
Aug 08
2025
|
Charles J Homcy |
SELL
Open market or private sale
|
Direct |
250,000
-10.72%
|
$11,500,000
$46.25 P/Share
|
|
Aug 08
2025
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-0.64%
|
$1,840,000
$46.3 P/Share
|
|
Aug 07
2025
|
Maricel Apuli Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
1,000
-0.7%
|
$45,000
$45.44 P/Share
|
|
Aug 07
2025
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-0.63%
|
$1,800,000
$45.37 P/Share
|
|
Aug 05
2025
|
Andrea Ellis |
SELL
Open market or private sale
|
Direct |
17,167
-48.01%
|
$841,183
$49.0 P/Share
|
|
Aug 05
2025
|
Andrea Ellis |
BUY
Exercise of conversion of derivative security
|
Direct |
17,167
+32.44%
|
$274,672
$16.75 P/Share
|
|
Jul 02
2025
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-1.23%
|
$1,680,000
$42.73 P/Share
|
|
Jul 01
2025
|
Neil Kumar Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
40,000
-0.61%
|
$1,680,000
$42.7 P/Share
|
|
Jun 27
2025
|
Viking Global Investors LP |
SELL
Open market or private sale
|
Indirect |
3,500,000
-15.87%
|
$154,000,000
$44.0 P/Share
|
|
Jun 27
2025
|
Charles J Homcy |
SELL
Bona fide gift
|
Direct |
20,000
-1.62%
|
-
|
|
Jun 26
2025
|
Hannah Valantine Director |
SELL
Open market or private sale
|
Indirect |
2,289
-48.71%
|
$100,716
$44.08 P/Share
|
|
Jun 26
2025
|
Hannah Valantine Director |
SELL
Open market or private sale
|
Direct |
2,418
-12.99%
|
$106,392
$44.06 P/Share
|
|
Jun 24
2025
|
Frank Mccormick Director |
SELL
Open market or private sale
|
Indirect |
100,000
-10.2%
|
$4,400,000
$44.23 P/Share
|
|
Jun 20
2025
|
Jennifer E. Cook |
BUY
Grant, award, or other acquisition
|
Direct |
6,589
+32.41%
|
-
|
|
Jun 20
2025
|
Andrea Ellis |
BUY
Grant, award, or other acquisition
|
Direct |
6,589
+26.17%
|
-
|
|
Jun 20
2025
|
Andrew Lo Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,589
+10.75%
|
-
|
|
Jun 20
2025
|
Ali J. Satvat |
BUY
Grant, award, or other acquisition
|
Direct |
6,589
+3.82%
|
-
|
|
Jun 20
2025
|
Ronald J Daniels Director |
BUY
Grant, award, or other acquisition
|
Direct |
6,589
+27.94%
|
-
|